Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -35.07% is 1478% below its 3-year average of 2.54%, near the low end of its 3-year range (-35.07%–16.00%).
As of the fiscal period ended Monday, June 30, 2025. 267.80% below its 12-month average of -9.54%.
Annual fiscal-year return on invested capital; no daily interpolation. Historical series through 2025-06-30.
RETURN ON INVESTED CAPITAL (ROIC)
-35.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-9.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
2.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-267.80%
CURRENT VS 3Y AVG
-1478.00%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.19%
median of 428 covered companies
CURRENT VS SECTOR MEDIAN
-28.98%
vs the sector median at left
Basel Medical Group Ltd Ordinary Shares
Market Cap
$4.96M
Return on Invested Capital (ROIC)
-35.07%
TTM Avg
-9.54%
3Y Avg
2.54%
5Y Avg
N/A
Market Cap
$4.99M
Return on Invested Capital (ROIC)
-27.41%
TTM Avg
-21.46%
3Y Avg
-17.98%
5Y Avg
-12.44%
Market Cap
$4.85M
Return on Invested Capital (ROIC)
-122.56%
TTM Avg
-179.66%
3Y Avg
-275.36%
5Y Avg
-182.57%
Market Cap
$4.79M
Return on Invested Capital (ROIC)
-38.23%
TTM Avg
-122.97%
3Y Avg
-1403.32%
5Y Avg
-860.06%
Market Cap
$5.21M
Return on Invested Capital (ROIC)
-126.69%
TTM Avg
-289.57%
3Y Avg
-198.60%
5Y Avg
-147.26%
Market Cap
$5.36M
Return on Invested Capital (ROIC)
-156.69%
TTM Avg
-654.50%
3Y Avg
-599.09%
5Y Avg
-420.09%
Market Cap
$4.46M
Return on Invested Capital (ROIC)
-246.61%
TTM Avg
-463.24%
3Y Avg
-303.42%
5Y Avg
-359.05%
Market Cap
$4.42M
Return on Invested Capital (ROIC)
-221.32%
TTM Avg
-119.11%
3Y Avg
-77.97%
5Y Avg
-64.48%
Market Cap
$4.41M
Return on Invested Capital (ROIC)
-346.94%
TTM Avg
-467.60%
3Y Avg
-296.93%
5Y Avg
-277.74%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Basel Medical Group Ltd Ordinary Shares (BMGL) | $4.96M | -35.07% | -9.54% | 2.54% | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | -27.41% | -21.46% | -17.98% | -12.44% |
| CalciMedica, Inc. (CALC)vs › | $4.85M | -122.56% | -179.66% | -275.36% | -182.57% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.79M | -38.23% | -122.97% | -1403.32% | -860.06% |
| Imunon, Inc. (IMNN)vs › | $5.21M | -126.69% | -289.57% | -198.60% | -147.26% |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | -156.69% | -654.50% | -599.09% | -420.09% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | -246.61% | -463.24% | -303.42% | -359.05% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.42M | -221.32% | -119.11% | -77.97% | -64.48% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | -346.94% | -467.60% | -296.93% | -277.74% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -116.89% | -117.72% | -83.78% | -61.46% |
ROIC
-35.1%
ROE
-248.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-06-30 | -35.07% |
| 2024-06-30 | 16.00% |
| 2023-06-30 | 13.81% |
| 2022-06-30 | 15.44% |
